Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Ruiping Dong"'
Autor:
Min Huang, Chengping Ma, Yan Li, Ruiping Dong, Rongrong Pang, Shuizhen Huang, Qiang Fu, Libo Zhang
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-9 (2023)
Abstract The accuracy of blood group identification is the basis of blood transfusion safety. In order to increase the detection rate of weak agglutination, unexpected antibodies (UAb) and blood subtypes for pre-transfusion testing, the blood group s
Externí odkaz:
https://doaj.org/article/8dbde5bb56a941aa95a6f89805c85b8d
Autor:
Ting Xu, Qiong Hua, Haolan Lu, Wael A. Harb, John Gong, Cody J. Peer, Yue He, Siying Xu, David T.L. Liu, Ruiping Dong, Kyriakos P. Papadopoulos, Ni Lu
Publikováno v:
Oncologist
Lessons Learned Subcutaneous injection was an effective route of administration for envafolimab with a favorable pharmacokinetic profile in patients with previously treated advanced solid tumors. Subcutaneous envafolimab was well tolerated and had du
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f752d381ffe5d46a68a748dbed37371
https://doi.org/10.1002/onco.13817
https://doi.org/10.1002/onco.13817
Autor:
Yi Chen, Ruiping Dong, Min Huang, Yi Su, Jian Ding, Shuai Tang, Meiyu Geng, Li Lei, Leping Li
Publikováno v:
Cancer Research. 80:3760-3760
The mitogen-activated protein kinases (MAPK) pathway, often known as the RAS-RAF-MEK-ERK signal cascade, is the most frequently mutated signal pathway in cancer, which makes the components of this pathway attractive targets for anticancer drug develo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::289153a02ffadb466b0816354b91fb4c
https://doi.org/10.1158/1538-7445.am2020-3760
https://doi.org/10.1158/1538-7445.am2020-3760
Autor:
Shilin Xue, Wenlian Xu, Ni Lu, Ruiping Dong, Danming Zhu, Toshio Shimizu, Meng Fu, Pilin Wang, Takako Eguchi Nakajima, Xiaoxiao Wang, Ting Xu, Haolan Lu, John Gong, Walt Cao, David T.L. Liu
Publikováno v:
Journal of Clinical Oncology. 37:2609-2609
2609 Background: KN035 is a novel fusion protein of humanized anti-PD-L1 single domain antibody and human IgG1 Fc, formulated for subcutaneous (SC) injection. A phase I safety and pharmacokinetic (PK) study was conducted in Japanese patients. Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ca45bedaac0843ec98cc878ba3a600b8
https://doi.org/10.1200/jco.2019.37.15_suppl.2609
https://doi.org/10.1200/jco.2019.37.15_suppl.2609
Autor:
Ruiping Dong, Yun Zhang, Huilong Liu, John Gong, David T.L. Liu, Rongrui Liu, Walt Cao, Shukui Qin, Chuanhua Zhao, Yaoyue Zhang, Meng Fu, Gairong Zhang, Jianming Xu, Pilin Wang, Ni Lu, Xiaoxiao Wang, Haolan Lu, Wenlian Xu, Ru Jia, Ting Xu
Publikováno v:
Journal of Clinical Oncology. 37:2608-2608
2608 Background: KN035 is a novel fusion protein of humanized anti-PD-L1 single domain antibody and human IgG1 Fc fragment, formulated for subcutaneous (SC) injection. Methods: The escalation phase followed a modified 3+3 design with a 28-day DLT eva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::05a08bc896192f289af649adf4813f6b
https://doi.org/10.1200/jco.2019.37.15_suppl.2608
https://doi.org/10.1200/jco.2019.37.15_suppl.2608
Autor:
Xiaoxiao Wang, Ni Lu, Gairong Zhang, Pilin Wang, Lin Yihui, Wenlian Xu, Yaoyue Zhang, Xiaoyu Ma, Chuanhua Zhao, Rongrui Liu, Ruiping Dong, Yun Zhang, Shukui Qin, Jianming Xu, Ting Xu, Liwei Yuan, Ru Jia, John Gong, Yan Wang, Yue He
Publikováno v:
Journal of Clinical Oncology. 36:e15138-e15138
e15138Background: KN035 is a novel programmed death-ligand 1(PD-L1) antagonist and formulated to high protein concentration (200 mg/ml) and provided as a transparent liquid solution for subcutaneou...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0eefee5a7b5b15bed84600e95ddd347f
https://doi.org/10.1200/jco.2018.36.15_suppl.e15138
https://doi.org/10.1200/jco.2018.36.15_suppl.e15138
Autor:
Xiaodan Feng, Ming Li, Wen Sun, Ruiping Dong, Jing Wang, Jiaqi Tang, Xiuzhen Pan, Gong Cheng, Hongfeng Ji, Dan Hu, Junchao Ge, Youjun Feng, Feng Zheng, Changjun Wang, Bo Wu, Fuquan Hu, Xina Hao, Zhimin Yin, Peiju Shi
Publikováno v:
Journal of Bacteriology. 191:2601-2612
Streptococcus suis serotype 2 is an emerging zoonotic pathogen responsible for a wide range of life-threatening diseases in pigs and humans. However, the pathogenesis of S. suis serotype 2 infection is not well understood. In this study, we report th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a38c2bacbeeadfdadaeb7cbdedc90c5a
https://doi.org/10.1128/jb.01309-08
https://doi.org/10.1128/jb.01309-08
Autor:
Arata Goto, RuiPing Dong
Publikováno v:
Haigan. 46:267-275
CetuximabはマウスとヒトIgG1のキメラ型モノクローナル抗体であり，ヒト上皮増殖因子受容体（EGFR）を標的としている．CetuximabはヒトEGFRの細胞外領域に結合し，リガンド結合を競合的に阻
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c0cdd5cff25985fb120dfa6543cb8f86
https://doi.org/10.2482/haigan.46.267
https://doi.org/10.2482/haigan.46.267
Autor:
Gong Cheng, Youjun Feng, Jing Wang, Xiaodan Feng, Jiaqi Tang, Ruiping Dong, Ming Li, Changjun Wang, Yaqing Dong, Fuquan Hu, Di Liu, Dan Hu, Junchao Ge, Xiuzhen Pan, Feng Zheng, Min Cao
Publikováno v:
Archives of microbiology. 191(1)
Sortase A (SrtA), originally identified as a transpeptidase in Staphylococcus aureus, plays key roles in full virulence of pathogenic bacteria. In silico genome-wide search suggested a srtA homologue from 05ZYH33, a Chinese human isolate of streptoco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d45ce225cf69308e4c5873b6de7c515c
https://pubmed.ncbi.nlm.nih.gov/18716756
https://pubmed.ncbi.nlm.nih.gov/18716756
Autor:
RuiPing Dong
Publikováno v:
Nature Reviews Drug Discovery. 11:100-100
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::795466d70eee2f1e25adcb3211e24ebb
https://doi.org/10.1038/nrd3668
https://doi.org/10.1038/nrd3668